BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 11770867)

  • 1. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
    Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment.
    Drosopoulos JH; Broekman MJ; Islam N; Maliszewski CR; Gayle RB; Marcus AJ
    Biochemistry; 2000 Jun; 39(23):6936-43. PubMed ID: 10841775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model.
    Buergler JM; Maliszewski CR; Broekman MJ; Kaluza GL; Schulz DG; Marcus AJ; Raizner AE; Kleiman NS; Ali NM
    J Thromb Thrombolysis; 2005 Apr; 19(2):115-22. PubMed ID: 16052302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.
    Pinsky DJ; Broekman MJ; Peschon JJ; Stocking KL; Fujita T; Ramasamy R; Connolly ES; Huang J; Kiss S; Zhang Y; Choudhri TF; McTaggart RA; Liao H; Drosopoulos JH; Price VL; Marcus AJ; Maliszewski CR
    J Clin Invest; 2002 Apr; 109(8):1031-40. PubMed ID: 11956240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease.
    El-Omar MM; Islam N; Broekman MJ; Drosopoulos JH; Roa DC; Lorin JD; Sedlis SP; Olson KE; Pulte ED; Marcus AJ
    Thromb Res; 2005; 116(3):199-206. PubMed ID: 15935828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1).
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
    J Thromb Haemost; 2003 Dec; 1(12):2497-509. PubMed ID: 14675084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
    Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
    J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human solCD39 inhibits injury-induced development of neointimal hyperplasia.
    Drosopoulos JH; Kraemer R; Shen H; Upmacis RK; Marcus AJ; Musi E
    Thromb Haemost; 2010 Feb; 103(2):426-34. PubMed ID: 20024507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
    Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis.
    Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S
    Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of extracellular ATP metabolism in regulation of platelet reactivity.
    Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
    J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated transfer of human placental ectonucleoside triphosphate diphosphohydrolase to vascular smooth muscle cells suppresses platelet aggregation in vitro and arterial thrombus formation in vivo.
    Furukoji E; Matsumoto M; Yamashita A; Yagi H; Sakurai Y; Marutsuka K; Hatakeyama K; Morishita K; Fujimura Y; Tamura S; Asada Y
    Circulation; 2005 Feb; 111(6):808-15. PubMed ID: 15699260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of functional recombinant mosquito salivary apyrase: a potential therapeutic platelet aggregation inhibitor.
    Sun D; McNicol A; James AA; Peng Z
    Platelets; 2006 May; 17(3):178-84. PubMed ID: 16702045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
    Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
    Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboregulation by endothelial cells: significance for occlusive vascular diseases.
    Marcus A; Broekman M; Drosopoulos J; Pinsky D; Islam N; Gayle R; Maliszewski C
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):178-82. PubMed ID: 11156849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutants.
    Musi E; Islam N; Drosopoulos JH
    Arch Biochem Biophys; 2007 May; 461(1):30-9. PubMed ID: 17374358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.